Wells Fargo & Company Better Therapeutics, Inc. Transaction History

Wells Fargo & Company

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 09, 2024	BUY	$0.14 - $0.39 $8 - $22	58 Added 47.93%	179 $0
Q3 2023 Nov 13, 2023	BUY	$0.34 - $1.23 $1 - $4	4 Added 3.42%	121 $0
Q2 2023 Aug 15, 2023	BUY	$0.69 - $1.46 $41 - $87	60 Added 105.26%	117 $0
Q4 2022 Feb 13, 2023	BUY	$1.1 - $1.74 $2 - $3	2 Added 3.64%	57 $0
Q3 2022 Nov 14, 2022	SELL	$1.53 - $2.77 $15 - $27	-10 Reduced 15.38%	55 $0
Q2 2022 Aug 12, 2022	BUY	$0.91 - $2.34 $4 - $11	5 Added 8.33%	65 $0
Q1 2022 May 16, 2022	BUY	$1.98 - $5.01 $1 - $5	1 Added 1.69%	60 $0
Q4 2021 Feb 14, 2022	BUY	$4.58 - $17.14 $270 - $1,011	59 New	59 $0

Ticker BTTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 23,743,000
Description
Better Therapeutics, Inc. engages in developing software-based prescription digital therapeutics (PDT) platform candidates for treating diabetes, heart disease, and other cardiometabolic conditions in the United States. Its lead product candidate in development is BT-001, an investigational PDT platform that uses digitally delivered Nutritional ...

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

Stay updated on Wells Fargo & Company with notifications on news.